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Abstract
Background: Clostridium difficile is the major cause of antibiotic associated diarrhoea and in recent years its
increased prevalence has been linked to the emergence of hypervirulent clones such as the PCR-ribotype 027.
Characteristically, C. difficile infection (CDI) occurs after treatment with broad-spectrum antibiotics, which disrupt the
normal gut microflora and allow C. difficile to flourish. One of the relatively unique features of C. difficile is its ability
to ferment tyrosine to para-cresol via the intermediate para-hydroxyphenylacetate (p-HPA). P-cresol is a phenolic
compound with bacteriostatic properties which C. difficile can tolerate and may provide the organism with a
competitive advantage over other gut microflora, enabling it to proliferate and cause CDI. It has been proposed
that the hpdBCA operon, rarely found in other gut microflora, encodes the enzymes responsible for the conversion
of p-HPA to p-cresol.
Results: We show that the PCR-ribotype 027 strain R20291 quantitatively produced more p-cresol in-vitro and was
significantly more tolerant to p-cresol than the sequenced strain 630 (PCR-ribotype 012). Tyrosine conversion to p-
HPA was only observed under certain conditions. We constructed gene inactivation mutants in the hpdBCA operon
in strains R20291 and 630Δerm which curtails their ability to produce p-cresol, confirming the role of these genes
in p-cresol production. The mutants were equally able to tolerate p-cresol compared to the respective parent
strains, suggesting that tolerance to p-cresol is not linked to its production.
Conclusions: C. difficile converts tyrosine to p-cresol, utilising the hpdBCA operon in C. difficile strains 630 and
R20291. The hypervirulent strain R20291 exhibits increased production of and tolerance to p-cresol, which may be
a contributory factor to the virulence of this strain and other hypervirulent PCR-ribotype 027 strains.
Background
Clostridium difficile is a spore forming Gram-positive
anaerobe and is the leading cause of hospital-acquired
diarrhoea worldwide [1,2]. The hospital environment
and patients undergoing antibiotic treatment provide a
discrete ecosystem where C. difficile persists and
selected virulent clones thrive. The recent upsurge in
the number of C. difficile infection (CDI) cases has been
linked to the rapid emergence of highly virulent and epi-
demic strains, known as PCR-ribotype 027. In the UK
prior to 2005, 027 strains were rarely reported, but they
now cause >33% of the 50,000 cases of CDI reported
annually [3]. Several studies have revealed that patients
infected with PCR-ribotype 027 strains have more severe
diarrhoea, higher mortality and higher level of recur-
rence [4-8]. This is exemplified by the strain R20291, a
prototypical PCR-ribotype 027 strain responsible for the
infection of over 160 patients at the Stoke Mandeville
hospital, UK in 2004/2005 [9].
CDI characteristically occurs after treatment with
broad-spectrum antibiotics. It is thought that antibiotic
treatment disrupts the normal gut microflora, providing
C. difficile with a competitive advantage to colonise the
gut mucosa. The reason why C. difficile flourish under
these conditions is unknown. Following colonisation,
toxin production via TcdA and TcdB results in an acute
inflammatory-response and severe damage to the intest-
inal epithelium [10]. These two widely studied toxins
are thought to be the main contributors to histopathol-
ogy and disease burden. However, recent outbreaks of
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toxin defective (A-B+) strains and are generally PCR-
ribotype 017 [11,12]. This suggests that other factors are
involved in C. difficile pathogenesis, survival and
proliferation.
One of the relatively unique properties of C. difficile
amongst anaerobes is its ability to produce p-cresol, a
phenolic compound produced by the degradation of tyr-
osine via para-hydroxyphenylacetate (p-HPA) [13]. Sev-
eral studies have shown p-cresol is bacteriostatic and
inhibits the growth of other bacteria [14]. The produc-
tion of p-cresol by C. difficile may provide the bacterium
with a competitive advantage over the other gut micro-
flora and facilitate the establishment of the pathogen.
Furthermore, the organism itself must have inherent
mechanisms to avoid or tolerate the toxic effects of
p-cresol that may be linked with its ability to produce
p-cresol. In C. difficile it has been hypothesised that
p-cresol is produced via the oxidation of tyrosine to
p-HPA followed by the decarboxylation of p-HPA to
p-cresol [15]. However, the temporal production of
p-cresol and its relative production among different
C. difficile strains have not been investigated. Genome
sequencing of the strain 630 (PCR-ribotype 012) sug-
gests that the p-HPA decarboxylase is encoded by three
genes (CD0153-CD0155) designated hpdBCA [16]. How-
ever, the genes involved in the conversion of tyrosine to
p-HPA are unknown.
In this study we demonstrate the temporal and quan-
titative production of p-cresol by C. difficile in both
minimal and rich media (supplemented with the inter-
mediate p-HPA) using NMR spectroscopy and gas chro-
matography (zNose™). Gene inactivation mutations in
the hpdA, hpdB and hpdC genes in strains 630Δerm and
R20291 confirmed the absence of p-cresol production in
all mutants tested and conclusively show that tyrosine is
converted to p-HPA by C. difficile under minimal media
growth conditions. We show that R20291 is more toler-
ant to p-cresol and has a higher capacity to convert
tyrosine to p-HPA resulting in higher overall levels of
p-cresol.
Results
Para-cresol tolerance and production
The tolerance of strains 630 and R20291 to p-cresol was
assessed in BHI broth as CFU counts per ml, expressed
as a proportion of the untreated control for a four hour
incubation period with 0.1% p-cresol (Figure 1). Strain
R20291 (PCR-ribotype 027) showed a significant
increase in survival to 0.1% p-cresol compared to strain
630 (PCR-ribotype 012) p < 0.01 using a Student’s t-test
(Figure 1). There was no significant difference in toler-
ance to p-cresol between 630 and 630Δerm, an erythro-
mycin sensitive spontaneous mutant (data not shown).
The 630Δerm strain was essential to construct and
select gene inactivation mutants for further investiga-
tions of p-cresol tolerance and production, therefore
subsequent analysis was performed with the 630Δerm
strain.
The production of p-cresol in-vitro was assessed in
rich media using two complementary methods, NMR
spectroscopy (Figure 2A) and zNose™ (Figure 2B). The
production of p-cresol was not detected in the C. diffi-
cile strains 630Δerm or R20291 cultured to stationary
phase in rich media (BHI broth, or BHI broth supple-
mented with cysteine) using either method, despite the
availability of tyrosine (data not shown). However, when
the strains were grown to stationary phase in rich media
supplemented with 0.1% p-HPA, p-cresol was readily
detected by NMR spectroscopy (Figure 2A) and
zNose™ (Figure 2B) in both the 630Δerm and R20291
parent strains. The NMR spectroscopy data revealed the
conversion of p-HPA to p-cresol was almost complete,
whereas the level of tyrosine remained constant
throughout all the samples and the media controls, sug-
gesting that under these conditions the conversion of
tyrosine to p-HPA was not possible (Figure 2A). The
ability of both strains to convert p-HPA to p-cresol in
BHI, yet the inability to convert tyrosine via p-HPA to
p-cresol indicates that constituents in the rich media
may inhibit the conversion of tyrosine to p-cresol.
Construction of gene inactivation mutants in C. difficile
Three co-located genes (hpdB, hpdC and hpdA)a r e
thought to encode the decarboxylase that converts
p-HPA to p-cresol in strains 630Δerm and R20291.
Gene inactivation mutants were constructed using the
ClosTron method [17] in strains 630Δerm (mutants
630ΔermΔhpdB and 630ΔermΔhpdC) and strain R20291
(mutants R20291ΔhpdA and R20291ΔhpdC). The group
II intron from the ClosTron system was retargeted
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Figure 1 Tolerance to p-cresol. Strains R20291 and 630 were
tested for their in-vitro tolerance to 0.1% p-cresol. * indicates a
significant difference p < 0.01 Student’s T-test.
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Page 2 of 10using the Sigma TargeTron algorithm to insert into
hpdA, hpdB and hpdC in the sense orientation for hpdA
and hpdC at position 254 bp and 174 bp, respectively
(from the start of the ORF), and in the antisense orien-
tation for hpdB at 748 bp (Figure 3A). Verification of
successful mutant construction was performed using
three independent PCR screens (Figure 3B). The RAM
specific PCR confirmed the loss of the group I intron
interrupting the ermB RAM, indicating chromosomal
integration of the intron. The gene specific and the
intron specific primer revealed insertion of the RAM
into the target gene, and the gene specific primers flank-
ing the insertion site revealed an increase in 1.9 kb in
size for the mutants compared to the wild-type
(Figure 3B). The insertion site was verified by sequen-
cing and by Southern blot analysis of the mutants using
the intron specific probe which confirmed insertion of a
single site-specific group II intron for all the hpdBCA
operon mutants tested (Figure 3C).
Analysis of the decarboxylase mutants
Initial growth dynamics and NMR spectroscopy analy-
sis revealed that the hpdB, hpdC and hpdA mutants
were indistinguishable in terms of the complete lack of
p-cresol production in rich media supplemented with
p-HPA (Figure 4A). Subsequent analysis was per-
formed with the hpdC mutants as these were con-
structed in both parent strains R20291 and 630Δerm.
Growth curves in minimal media (YP broth) revealed
that the R20291ΔhpdC mutant grew significantly better
than the parent strain R20291, however, no significant
difference in in-vitro growth was observed between
630ΔermΔhpdC and the respective parent strain (Fig-
ure 4B). There were no significant differences between
the tolerance of the mutants R20291ΔhpdC and
630ΔermΔhpdC to 0.1% p-cresol compared to their
respective parent strains (Figure 4C), however, the
R20291 strains (wild-type and R20291ΔhpdC)a r es i g -
nificantly more tolerant to p-cresol than their 630
counterparts (wild-type and 630ΔermΔhpdC) (p <
0.01). The absence of p-cresol production observed in
the R20291ΔhpdC and 630ΔermΔhpdC mutants by
NMR spectroscopy in rich media supplemented with
0.1% p-HPA (Figure 4A), was reproducible in minimal
media using zNose™ gas chromatography (data not
shown).
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Figure 2 Detection and production of p-cresol by 630Δerm and R20291 using NMR spectroscopy and zNose™ gas chromatography.
The relative production of p-cresol in rich media (BHI) supplemented with 0.1% p-HPA for strains 630Δerm and R20291 by A) NMR spectroscopy
and B) zNose™ gas chromatography. The p-cresol peak is indicated with an arrow, at 6.7 seconds for zNose™ experiments
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Page 3 of 10Temporal production of p-HPA and p-cresol in mutant
and parent strains
Preliminary NMR spectroscopy revealed that p-cresol
was produced in unsupplemented minimal media (YP
broth), indicating that the available tyrosine was con-
verted to p-cresol via the intermediate p-HPA. The tem-
poral production of p-HPA and p-cresol were assessed
i nm i n i m a lY Pm e d i a ,u s i n gboth wild-type and mutant
strains of R20291 and 630Δerm. For each strain, samples
were taken every hour for the first 8 hours with a final
time point of 24 hours, after which the relative produc-
tion of p-HPA and p-cresol were determined by NMR
spectroscopy, the combined data for all the strains and
controls is presented in Figure 5A. High levels of tyro-
sine were present in all samples including the media
control (Figure 5A); however, the conversion to p-HPA
and p-cresol across all the strains was limited to a few
samples (Figure 5A), namely the latter time points in
the parent strains. In the decarboxylase mutants
R20291ΔhpdC and 630ΔermΔhpdC,ab u i l du po fp-
HPA was evident from 4 to 24 hours (Figure 5B and
5C). The level of p-HPA production was significantly
higher in the R20291ΔhpdC mutant compared to the
630ΔermΔhpdC mutant (Figure 5B and 5C). As pre-
dicted, p-cresol was not detected in the mutant samples.
In the parent strains p-cresol production was detected
at 4 hours and increased until the levels reached a peak
at 24 hours (Figure 5C), but the relative level of p-cresol
produced was significantly higher in R20291 than
630Δerm.
Discussion
In this study we show two independent methods for
measuring levels of p-cresol from C. difficile grown in
vitro. NMR spectroscopy and gas chromatography
(zNose™) provide a quantitative means of measuring
the relative and temporal production of p-cresol by C.
difficile. This revealed that that p-cresol is only pro-
duced from the conversion of tyrosine in minimal
media. indicating that p-cresol production may be linked
to the limitation of nutrients, or nutrient stress. How-
ever, the successful conversion of p-HPA to p-cresol in
ǍhpdC
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Figure 3 The hpdBCA operon and verification of mutant construction.T h ehpdBCA operon with insertion sites for the targeted ClosTron
mutagenesis, the number refers to the insertion site (bp) and the s/a refers to sense/antisense orientation of the ClosTron insert. B) PCR screen
of the mutants (M = mutant; W = wild type; P = plasmid and “-” negative control). Three PCR screens were performed, gene specific forward
and reverse primers, intron specific with gene specific primers, and RAM specific primers (Heap et al., 2007). C) Southern blot using a probe
specific to the inserted intron. HindIII digests were performed on DNA from M = mutant; W = wild type; P = plasmid. The strains and primer
sets are indicated on each figure and in tables 1 and 2. The marker sizes are indicated on the figure and the expected band sizes are as follows
for 630Δerm: hpdB 2.8Kb; hpdC 3.4 kb and for R20291: hpdA - 6.3 kb; hpdC - 3.4 kb.
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Page 4 of 10rich media suggests the limiting step in the cascade is
the utilisation of tyrosine. Rich media may contain a
constituent(s) such as glucose, which inhibits the con-
version from tyrosine to p-HPA.
Gene inactivation mutations in the hpdB, hpdC and
hpdA genes in strains 630Δerm and R20291 revealed the
complete absence of p-cresol production in all mutants
tested, confirming the role of the putative decarboxylase
operon in p-cresol production in C. difficile.T h eb u i l d
up of p-HPA observed in the hpdBCA operon mutants
confirm that C. difficile converts tyrosine to p-HPA,
rather than using an exogenous source of p-HPA and
this conversion is significantly more efficient in R20291.
With the exception of Clostridium scatologenes,t h e
hpdBCA operon appears absent from the genomes of
other sequenced anaerobic bacteria [18]. The production
of p-cresol coupled with its ability to produce tissue-
damaging toxins may explain why C. difficile is almost
unique among pathogens in causing antibiotic associated
colitis. The production of p-cresol by C. difficile may
provide a competitive advantage over other microorgan-
isms during re-colonisation of the gut. If this hypothesis
is true, C. difficile should itself be tolerant to the
bacteriostatic properties of p-cresol. Previous studies
have shown that in contrast to most other anaerobes, C.
difficile is more tolerant to p-cresol [14]. We have also
shown that the modern hypervirulent 027 clonal lineage
has a propensity to be more tolerant to p-cresol than
other strains, as observed with BI-16, a recent 027 iso-
lated which exhibits a level of tolerance similar to
R20291. The historic 027 isolate CD196 exhibits a simi-
lar level of tolerance to strain 630 [18]. This increase in
tolerance to p-cresol in the modern hypervirulent 027
isolates may be linked to increased virulence.
In addition, the hypervirulent PCR-ribotype 027 strain
has a higher capacity to convert tyrosine to p-HPA
resulting in a higher overall yield of p-cresol. Analysis of
the decarboxylase mutants revealed that although C. dif-
ficile can tolerate p-cresol, high levels have a deleterious
effect on the growth rate of C. difficile,a st h em u t a n t s
grow better in-vitro than their respective parent strains.
Although it is evident that the 027 ribotype R20291 is
more tolerant to p-cresol and produces significantly
more p-cresol than other strains, the mechanism of tol-
erance to p-cresol does not appear to be linked to its
production. These results indicate that there is an
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Page 5 of 10intricate balance between optimal p-cresol production
and deleterious effects on growth.
Conclusions
The hypervirulent R20291 strain produces high levels of
p-cresol, and has an elevated tolerance, which may con-
tribute to the colonisation and dissemination of the 027
clonal lineage by providing a selective advantage. There
is a delicate interplay between relative p-cresol produc-
tion and growth rate, whereby R20291 may have
reached an advantageous compromise.
Materials and methods
Bacterial strains and culture
C. difficile strains used in this study were 630, 630Δerm and
R20291. Strain 630, PCR-ribotype 012, was originally iso-
lated from a patient with severe PMC in Zurich, Switzer-
land in 1982. 630Δerm is an erythromycin sensitive strain
that was isolated after passage of the original sequenced
strain 630 [19]. Erythromycin sensitivity is required for the
construction of C. difficile gene inactivation mutants.
R20291, a hypervirulent PCR-ribotype 027 strain was iso-
lated from an outbreak at Stoke Mandeville hospital in
2006 and was provided by Jon Brazier (Anaerobe reference
laboratory, Cardiff, UK). Strains were stored at -80°C and
were cultured on BHI Agar (Oxoid), supplemented with
0.05% L-cysteine and cycloserine/cefoxitin antibiotic supple-
ment (Fluka) at the recommended concentrations for 1 to 2
days under anaerobic conditions, in a Modular Atmosphere
Control System 500 (Don Whitney Scientific) at 37°C.
Liquid cultures were grown in BHI broth (Oxiod) supple-
mented with 0.05% L-cysteine and cycloserine/cefoxitin
antibiotic supplement (Fluka) with and without 0.1%
p-HPA (Sigma), or in yeast peptone (YP) broth, 16 gL
-1
peptone (Sigma), 5 gL
-1 yeast (Sigma), and 5 gL
-1 NaCl2
(Sigma). E. coli strain CA434, the conjugation donor, was
grown in Luria-Bertani (LB) broth or agar supplemented
with 12.5 μg/ml chloramphenicol.
Para-cresol tolerance assays
Primary cultures were inoculated with three single colo-
nies into pre-equilibrated media, shaking at 50 rpm on
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Figure 5 Temporal production of p-HPA and p-cresol in mutant and wild-type strains using NMR. A) NMR spectra showing an overview
of the relative levels of tyrosine, p-HPA and p-cresol from all replicates and strains tested over a 24-hour time period, the colours define the 44
samples used in the time course experiment, over four strains and media controls. T = time of sampling (hours post inoculation). B) The relative
production of p-HPA by mutant and patent strains over a 24-hour time period. C) The relative production of p-cresol by the parent strains over a
24-hour time period. (The levels of p-cresol by the ΔhpdC mutants were below the limits of detection by NMR and were not plotted).
Dawson et al. BMC Microbiology 2011, 11:86
http://www.biomedcentral.com/1471-2180/11/86
Page 6 of 10an orbital shaker. At an OD600 nm of 0.3-0.4, liquid cul-
tures were inoculated 1/10 into pre-equilibrated media
containing 0.05% (v/v) and 0.1% (v/v) p-cresol alongside
an untreated control. These were incubated under anae-
robic conditions for 4 hours before colony forming units
were performed in pre-equilibrated 1 × PBS (Sigma),
then plated in triplicate onto BHI plates and incubated
for 24 hours under anaerobic conditions. CFU counts
were determined for all of the test conditions and were
calculated per ml of culture. The p-cresol stress CFU
data was normalized to the untreated control and
expressed as a percentage. Data was analysed in Graph-
Pad Prism V4.02 using a two-tailed Student’st - t e s t s
with a p value cut off of p < 0.01.
NMR
Primary cultures of C. difficile were grown overnight as
outlined above in either BHI broth, BHI supplemented
with 0.1% p-HPA, or YP broth. Secondary cultures were
inoculated 1/10 from the primary cultures into the rele-
vant media. Samples were removed every hour up to 24
hours, the OD600 nm was taken and samples were double
filter sterilized using 0.2 μM filter, then stored at -80°C.
1H NMR spectroscopy analysis was carried out to
determine the production of p-cresol in rich media sup-
plemented with p-HPA, and for determination of the
temporal production of p-HPA and p-cresol in the
mutant and wild-type strains to yield the relative levels
of tyrosine and of the metabolites produced, p-HPA and
p-cresol. Spectra were obtainedu s i n gb u f f e r e de x t r a c t s
of the various cultures. Typically, 350 μl of sample was
transferred to a 5 mm Norell HP507 NMR tube, and
150 μl of a pH 7.4 phosphate buffer with TSP added as
a chemical shift reference was then added, providing a
final sample volume of 500 μl.
All
1H NMR spectroscopy was carried out on a Bruker
Avance-DRX600 instrument operating at 600.29 MHz,
using a 5 mm TXI probe (Bruker BioSpin GmbH, 76287
Rheinstetten, Germany). The standard 1-D pulse
sequence [RD-90°-t1-90°-tm-90°- acquire FID] was
employed for all acquisitions, with water peak suppres-
sion achieved through irradiation of the water signal dur-
ing tm and RD, using 8 dummy scans, a spectral width of
20.02 ppm, Fourier transform line broadening of 0.3 Hz,
tm = 150 ms, and t1 =3μs. The first acquisition program
for the rich media samples used 64 scans, 32 k time and
frequency domain points, and a relaxation delay (RD) of
3.5 s. The second acquisition run for the temporal ana-
lyses employed 128 scans, and used a higher spectral
resolution of 64 k time and frequency domain points,
with a reduced relaxation delay (RD) of 2.137 s to main-
tain the across-acquisition quantitation status of the
metabolites of interest. Within each run, the instrument
receiver gain was set to a constant value for all samples.
The temporal metabolite profile analyses were carried
out starting with Matlab R2008a (MathWorks Inc, Natick
MA, USA), using proprietary in-house routines for some
of the spectral import processing and for correlation ana-
lysis. Data was prepared and imported to Matlab initially
using MetaSpectra over the spectral region between 0
and ~10.1 ppm, using 32 k data points, which is very
close to the original acquisition digitisation density of 64
k over a 20.11 ppm sweep width. No spectral excision for
the water residual signal region was made. Under the
assumption of constant linewidth, relative quantitation
for p-HPA and p-cresol in this work was based on peak
heights for the higher shift peak from each doublet
(6.875 and 6.838 ppm). Peak height quantitation under
these assumptions has been shown to be a reliable quan-
titative approach [20]. The TSP peak height and line
width for the data array was used to verify this was a rea-
sonable assumption, as well as confirming volumetric
accuracy in sample preparation. This quantitation data
was then placed into an Excel spreadsheet for calculation
of the baseline corrected values, using the local baseline
taken from the broth control samples having zero p-HPA
and p-cresol present. Some STOCSY analysis of the data
arrays (data not shown) was also used to confirm the
conversion pathway sequence, by showing the appropri-
ate anti-correlations in the levels of precursor and con-
version metabolite [21]. The metabolite quantitation data
was then graphed using GraphPad Prism.
zNose™
The zNose™ is an ultra rapid analytical device that
allows real time monitoring of volatile compounds [22],
by combining miniaturised gas chromatograph separa-
tion technology with a highly sensitive acoustic wave
sensor. Primary and secondary cultures of C. difficile
were set-up as outlined above and harvested at
OD600nM 0.4 and at 24 hours, then these were trans-
ferred into pre-baked (overnight at 210°C) 40 ml glass
vials sealed with screw caps with an integral PTFE/sili-
cone septa (Supelco, Gillingham, UK).
Measurements were performed with a zNose™ Model
7100 bench top vapour analysis system (Electronic Sen-
sor Technology, Newbury Park, CA) fitted with a capil-
lary DB-624 column and a temperature controlled
surface acoustic wave (SAW) detector. Headspace sam-
ples were withdrawn from the sealed vials via a side
hole Luer needle inserted through the septum. Ten sec-
ond samples were taken at a flow rate of 0.5 ml/second.
All measurements were taken at ambient temperature.
The column was ramped at from 40°C to 160°C at 10
C/s in a helium flow of 3.00 cm
3.T h eS A Ws e n s o r
operated at a temperature of 60°C and data were col-
lected every 0.02 s. After each data sampling period the
sensor was baked for 30 s at 150°C to remove any
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cleaning of the system and a stable baseline. On
encountering compounds exiting the DB-624 column
the SAW detector registers a depression in the fre-
quency of the acoustic wave at its surface relative to a
reference sensor. Derivativisation is performed automati-
cally by the Microsense software (EST, Newbury Park,
CA) and retention time and peak sizes are plotted. A
r e f e r e n c es a m p l eo fp u r ep-cresol (Sigma) was run
under the same conditions to confirm that the retention
time of the experimental peak observed (6.7 s) was iden-
tical to that of the target compound.
Production of gene inactivation mutants
The genes of the hpdBCA operon were insertionally
inactivated using the ClosTron system in strains
630Δerm and R20291 [17]. The group II Ll.LtrB intron
was retargeted to hpdB, hpdC,a n dhpdA by SOEing
PCR as previously described [17] with oligonucleotides
(listed in Table 1) designed using the Sigma TargeTron
website (http://www.sigma-genosys.com/targetron/).
PCR products were cloned into pGEM
®-T Easy (Pro-
mega) as outlined in the manufacturer’sg u i d e l i n e st o
create the plasmids pLDhpdA1 and pLDhpdC1, listed in
Table 2. The sequence of the retargeted intron regions
were confirmed by sequencing using primers T7 and
SP6 with the BigDye
® Terminator v3.1 Cycle Sequen-
cing Kit (Applied Biosystems) in accordance with the
manufacturer’s guidelines.
The retargeted intron was then cloned into the Hin-
dIII and BsrGI sites of pMTL007 to create the plasmids
pLDhpdA2, pLDhpdB, and pLDhpdC2 (Table 2), which
were transformed into the E. coli conjugation donor
strain CA434 and transferred into C. difficile strains
630Δerm and R20291 by conjugation as previously
described [23]. Transconjugants were selected for in the
Table 1 List of oligonucleotides used in this study
Oligonucleotide Sequence
hpdB-IBS AAAAAAGCTTATAATTATCCTTATACCACTAAGCCGTGCGCCCAGATAGGGTG
hpdB-EBS1δ CAGATTGTACAAATGTGGTGATAACAGATAAGTCTAAGCCCATAACTTACCTTTCTTTGT
hpdB-EBS2 TGAACGCAAGTTTCTAATTTCGGTTTGGTATCGATAGAGGAAAGTGTCT
hpdA-IBS AAAAAAGCTTATAATTATCCTTAGGTATCGGCAAAGTGCGCCCAGATAGGGTG
hpdA-EBS1δ CAGATTGTACAAATGTGGTGATAACAGATAAGTCGGCAAATGTAACTTACCTTTCTTTG
hpdA-EBS2 TGAACGCAAGTTTCTAATTTCGATTATACCTCGATAGTGGAAAGTGTCT
hpdC-IBS AAAAAAGCTTATAATTATCCTTATATGTCATGGTAGTGCGCCCAGATAGGTG
hpdC-EBS1δ CAGATTGTACAAATGTGGTGATAACAGATAAGTCATGGTAAGTAACTTACCTTTCTTTGT
hpdC-EBS2 TGAACGCAAGTTTCTAATTTCGGTTACATATCGATAGAGGAAAGTGTCT
EBS universal CGAAATTAGAAACTTGCGTTCAGTAAAC
hpdB-F AATGCCATGGGTAAGTGAAAGC
hpdB-R GAATTGTATAAGTCAACTGAAGAGC
hpdCA-F GTGGATGCAACCAAAGGAAT
hpdC-R TTACAACTCAGTGGACATCCATT
hpdA-R TTAGAAAGCTGTCTCATGAC
RAM-F ACGCGTTATATTGATAAAAATAATAATAGTGGG
RAM-R ACGCGTGCGACTCATAGAATTATTTCCTCCCG
SalI-R1 ATTACTGTGACTGGTTTGCACCACCCTCTTCG
EBS2 TGAACGCAAGTTTCTAATTTCGGTTTGGTATCGATAGAGGAAAGTGTCT
Table 2 List of plasmids used in this study
Plasmid Relevant properties Source
pGEM
®-T Easy Commercial TA’ cloning plasmid Promega
pMTL007 ClosTron mutagenesis plasmid Heap et al. 2007
pLDhpdB pMTL007 carrying Ll.LtrB intron retargetted to hpdB This work
pLDhpdC1 pGEM
®-T Easy carrying Ll.LtrB intron retargetted to hpdC This work
pLDhpdC2 pMTL007 carrying Ll.LtrB intron retargetted to hpdC This work
pLDhpdA1 pGEM
®-T Easy carrying Ll.LtrB intron retargetted to hpdA This work
pLDhpdA2 pMTL007 carrying Ll.LtrB intron retargetted to hpdA This work
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Page 8 of 10presence of thiamphenicol (15 μg/ml, Sigma), after
which mobilisation of the intron from the plasmid to
the gene of interest was induced using IPTG. Screening
for chromosomal insertion of the intron was performed
with lincomycin (20 μg/ml, Sigma) for both C. difficile
630Δerm and R20291 to select for the restored ermB
retrotransposition-activated marker (RAM) that signals
integration into the genome. DNA was extracted for
analysis from colonies, which were phenotypically linco-
mycin resistant, but thiamphenicol sensitive to indicate
loss of the plasmid pMTL007. Potential mutants were
verified by PCR, sequencing and Southern blot analysis.
Screening of mutants by PCR, sequencing and Southern
blot
Potential mutants were screened by PCR, sequencing and
Southern blot analysis to confirm the chromosomal inte-
gration of the intron within the desired genes and loss of
the plasmid pMTL007. Three PCRs were performed to
screen putative mutants using the following oligonucleo-
tides (Table 1): i) RAM-F and RAM-R, to screen for loss
of the group I intron, which insertionally inactivated the
ermB RAM prior to chromosomal integration of the
group II intron; ii) a gene specific primer and the group
II intron specific EBS universal primer, to screen for
insertion of the intron into the desired location in the
genome; and iii) gene specific forward and reverse pri-
mers that flank the insertion site. Genomic DNA from C.
difficile R20291 and 630Δerm,a n dp l a s m i dD N Af r o m
pMTL007 were used as controls for the PCR reactions.
PCR reactions were performed with GoTaq
® PCR mix
(Promega) in accordance with the manufacturers guide-
lines. The thermal cycling conditions were as follows: 95°
C for 2 min × 1; 95°C for 30 sec, 50°C for 30 sec, 68°C for
8 min × 35 cycles; and 68°C for 10 min × 1.
Sequencing was performed across the junction of the
gene to intron using gene specific primers and the EBS
universal primer to verify insertion site. Southern blot
analyses were performed using Roche DIG-High Prime
DNA labelling and detection reagents, in accordance
with the manufacturer’s guidelines and visualised using
CDP star (Roche). Genomic DNA from wild type and
potential mutants was disgested with HindIII alongside
p l a s m i dD N Aa sap o s i t i v ec o n t r o l .T h ep r o b ew a sp r o -
duced by PCR using SaII-R1 and EBS2 primers (Table 1),
designed within the group II intron sequence.
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